Press Release Archive
Press Releases
August 2022
08.23.2022 Vaccines Covid-19 Vaccines Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
June 2022
06.29.2022 Vaccines Covid-19 Vaccines Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine 06.17.2022 Vaccines Covid-19 Vaccines Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age 06.06.2022 Financial Covid-19 Investments Vaccines Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.
May 2022
05.23.2022 Vaccines Covid-19 Vaccines Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose 05.17.2022 Vaccines Covid-19 Vaccines Pfizer and BioNTech Granted U.S. Emergency Use Authorization for Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age 05.13.2022 Vaccines Covid-19 Vaccines Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with European Commission
April 2022
04.26.2022 Covid-19 Vaccines Pfizer and BioNTech Submit Application for U.S. Emergency Use Authorization for a COVID-19 Vaccine Booster Dose in Children 5 Through 11 Years of Age 04.14.2022 Covid-19 Vaccines Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of Age
March 2022
03.29.2022 Covid-19 Vaccines Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older 03.22.2022 Covid-19 Vaccines Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries 03.15.2022 Covid-19 Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.